Evidence map›Paper›PMID 38191467›Full record

ArticleJournal of hematology & oncology2024

The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans.

Lawrence W Liu, Mei Wang, Nikhil Grandhi, Mark A Schroeder, Theodore Thomas, Kristin Vargo, Feng Gao, Kristen M Sanfilippo, Su-Hsin Chang

Open access · goldAbstract readLetter
In one paragraph

Article in Journal of hematology & oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Risk factors for multiple myeloma and its precursor diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lawrence W LiuResearch Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Mei WangResearch Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Nikhil GrandhiResearch Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Mark A SchroederDepartment of Medicine, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8056, St. Louis, MO, 63110, USA.
Theodore ThomasResearch Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Kristin VargoResearch Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Feng GaoDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8100, St. Louis, MO, 63110, USA.
Kristen M Sanfilippo *Research Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA.
Su-Hsin Chang *Research Service, St. Louis Veterans Affairs Medical Center, 501 N. Grand Blvd Suite 300, St. Louis, MO, 63103, USA. chang.su-hsin@wustl.edu.
Washington University in St. Louis · USCity of Hope · USSt. Louis VA Medical Center · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reductionU01CA265735 · NCI · WASHINGTON UNIVERSITY · PI CHANG, SU-HSIN, WANG, SHIYI · 2021 to 2025
$3.2M
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspectiveR01CA253475 · NCI · WASHINGTON UNIVERSITY · PI CHANG, SU-HSIN · 2020 to 2022
$1.1M
NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA253475NCI NIH HHS U01 CA265735
6 · The paper itself

Abstract

Herbicide and pesticide exposure [e.g., agent orange (AO)] is associated with an increased risk of multiple myeloma (MM) due to the contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). However, it is unclear whether TCDD/AO exposure (AO exposure hereafter) increases the risk of progression of monoclonal gammopathy of undetermined significance (MGUS) to MM. We sought to evaluate the association in a nationwide study of US Veterans. A natural language processing algorithm was used to confirm MGUS and progression to MM. We included Veterans who were diagnosed with MGUS from 10/1/1999 to 12/31/2021 and served during the Vietnam War Era from 1/9/1962 to 5/7/1975. AO exposure was stratified according to three TCDD exposure levels: high (1/9/1962-11/30/1965), medium (12/1/1965-12/31/1970), or low (1/1/1971-5/7/1975). The association between AO exposure and progression was analyzed using multivariable Fine-Gray subdistribution hazard model with death as a competing event. The analytic cohort included 10,847 Veterans with MGUS, of whom 26.3% had AO exposure and 7.4% progressed to MM over a median follow-up of 5.2 years. In multivariable analysis, high exposure was associated with an increased progression rate (multivariable-adjusted hazard ratio 1.48; 95% confidence interval 1.02-2.16), compared to Veterans with no exposure. This information is critical to inform progression risk in patients diagnosed with MGUS and prior AO exposure. It is also applicable to MGUS patients with occupational TCDD exposure from herbicides and pesticides.

Indexed as

HerbicidesMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaPolychlorinated DibenzodioxinsVeteransAgent OrangeHumansVietnamAgent OrangeHerbicidesPolychlorinated Dibenzodioxins

Identifiers

PMID38191467
PMCPMC10773019
OpenAlexW4390667927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.